Serum paraprotein persistence and size determine outcome in a cohort of patients with a modern definition of plasmacytoma with up to 19 years of follow up

在一组符合现代浆细胞瘤定义的患者中，血清副蛋白的持续存在和大小决定了预后，随访时间长达19年。